Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review - von Eyben, FE; Roviello, G; Kiljunen, T (Eur J Nucl Med Mol Imaging, 2018)
et al.